Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, March 23, 2015

Week In Review: China's And Eli Lilly Form $456 Million Cancer Biologics Alliance

Innovent Biologics of Suzhou will collaborate with Lilly to develop as many as six cancer-fighting biologic drugs ; Vivo Capital, a US-China healthcare investment company, closed its eighth fund at $750 million; Zhejiang ChiMin Pharma completed a Shanghai IPO, raising $47 million; South Korea's Hanmi Pharma out-licensed ex-China rights for its novel autoimmune treatment to Lilly in a $690 million deal; Jianshun Biosciences of Lanzhou will distribute an embryonic stem cell-based vaccine technology from France's Valneva in China; ZAI Lab of Shanghai dosed the first subject in a Phase I study of a novel respiratory treatment discovered by Sanofi; Ascletis, a US-China pharma, reported positive results from a Phase II trial of a hepatitis C drug; Aslan Pharma of Singapore announced a cancer drug was safe and well-tolerated in its initial Phase I trial; and Yisheng Biopharma, a China vaccine ... (more)

http://ift.tt/1IlzeXR

No comments:

Post a Comment

Popular Stem Cell Roundup Posts